Activity-based cost of platelet transfusions in medical and surgical inpatients at a US hospital [0.03%]
美国一家医院医学和外科住院患者血小板输注的活动基础成本
Axel Hofmann,Sherri Ozawa,Aryeh Shander
Axel Hofmann
Background and objectives: Previous studies by the Cost of Blood Consensus Conference (COBCON) have used a comprehensive, standardized and generalizable activity-based costing (ABC) model to estimate the cost of red blood...
Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic [0.03%]
新冠肺炎疫情期间采集恢复期血浆的教训
Silvano Wendel,Kevin Land,Dana V Devine et al.
Silvano Wendel et al.
Background: The lack of definitive treatment or preventative options for COVID-19 led many clinicians early on to consider convalescent plasma (CCP) as potentially therapeutic. Regulators, blood centres and hospitals worl...
Red blood cell storage duration and peri-operative outcomes in paediatric cardiac surgery [0.03%]
储存期限对儿科心脏手术围术期结果的影响研究
Asif Padiyath,Brian D Lo,Chin Siang Ong et al.
Asif Padiyath et al.
Background: Prior research on red blood cell (RBC) storage duration and clinical outcomes in paediatric cardiac surgery has shown conflicting results. The purpose of this study was to evaluate whether blood stored for a l...
Optimization of diagnostic strategy for non-invasive cell-free foetal RHD determination from maternal plasma [0.03%]
优化非侵入性胎儿RHD检测诊断策略的研究
Eva Pazourkova,Iveta Zednikova,Marie Korabecna et al.
Eva Pazourkova et al.
Background and objectives: The aim of the study was to optimize routine non-invasive prenatal detection of fetal RHD gene from plasma of RhD-negative pregnant women (the median of gestational age was 25 weeks, range 10-38...
International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Responses [0.03%]
国际无偿献血前晕及献血反应预防策略论坛：对策回应
Mindy Goldman,Mary Townsend,Karin Magnussen et al.
Mindy Goldman et al.
Sheila F O&#x;Brien,Henrik Ullum,Clive R Seed
Sheila F O&#x;Brien
High-titre anti-SARS-CoV-2 convalescent plasma donation after donors' vaccination [0.03%]
新冠康复者疫苗接种后的高滴度恢复期血浆捐献
Iñigo Romon,Jose L Arroyo,Teresa Díaz et al.
Iñigo Romon et al.
Impact of pathogen reduction methods on immunological properties of the COVID-19 convalescent plasma [0.03%]
不同除菌方法对新冠恢复期血浆免疫学特性的影响
Alexander I Kostin,Maria N Lundgren,Andrey Y Bulanov et al.
Alexander I Kostin et al.
Background and objectives: COVID-19 convalescent plasma is an experimental treatment against SARS-CoV-2. The aim of this study is to assess the impact of different pathogen reduction methods on the levels and virus neutra...
Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices [0.03%]
COVID-19状态下体外血浆交换技术初步指导和实践要点解读
Gopal K Patidar,Kevin J Land,Hans Vrielink et al.
Gopal K Patidar et al.
Background and objectives: Cytokine release syndrome in COVID-19 is due to a pathological inflammatory response of raised cytokines. Removal of these cytokines by therapeutic plasma exchange (TPE) prior to end-organ damag...
Exchange transfusions in severe Rh-mediated alloimmune haemolytic disease of the foetus and newborn: a 20-year overview on the incidence, associated risks and outcome [0.03%]
严重Rh所致胎儿和新生儿溶血病换血疗法20年回顾性研究：发生率、相关风险及预后
Isabelle M C Ree,Carolin F J Besuden,Vivianne E H J Wintjens et al.
Isabelle M C Ree et al.
Background and objectives: Guidelines and indications for exchange transfusion in haemolytic disease of the foetus and newborn (HDFN) have changed drastically in the past decades, causing a decline in exchange transfusion...
Observational Study
Vox sanguinis. 2021 Oct;116(9):990-997. DOI:10.1111/vox.13090 2021